Repligen Company Leadership

RGEN Stock  USD 167.86  3.42  2.00%   
About 75% of Repligen's corporate insiders are selling. The analysis of insiders' sentiment of trading Repligen stock suggests that many insiders are alarmed at this time. Repligen employs about 1.8 K people. The company is managed by 31 executives with a total tenure of roughly 179 years, averaging almost 5.0 years of service per executive, having 57.52 employees per reported executive.
Anthony Hunt  CEO
President CEO, Director
Alexander Rich  Chairman
Independent Chairman Emeritus of the Board

Repligen's Insider Buying Vs Selling

25

 
Selling
 
Buying

Latest Trades

2024-03-11Ralf KuriyelDisposed 3517 @ 193.73View
2024-03-08Anthony HuntDisposed 16707 @ 197.44View
2024-02-27Karen A DawesDisposed 1000 @ 193.35View
2024-02-23James BylundDisposed 4373 @ 198.08View
2023-11-10Christine GebskiDisposed 3788 @ 147.13View
2023-08-29Karen A DawesDisposed 850 @ 171.38View
2023-05-08Martin D MadausAcquired 500 @ 156.18View
2023-05-04Martin D MadausAcquired 500 @ 161.15View
Monitoring Repligen's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

Repligen's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Repligen's future performance. Based on our forecasts, it is anticipated that Repligen will maintain a workforce of about 1780 employees by May 2024.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Repligen's latest congressional trading

Congressional trading in companies like Repligen, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Repligen by those in governmental positions are based on the same information available to the general public.
2022-05-05Representative Josh GottheimerAcquired Under $15KVerify

Repligen Management Team Effectiveness

The company has return on total asset (ROA) of 0.0131 % which means that it generated a profit of $0.0131 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0214 %, meaning that it created $0.0214 on every $100 dollars invested by stockholders. Repligen's management efficiency ratios could be used to measure how well Repligen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of April 2024, Return On Tangible Assets is likely to grow to 0.03. Also, Return On Capital Employed is likely to grow to 0.02. At this time, Repligen's Intangible Assets are very stable compared to the past year. As of the 25th of April 2024, Net Tangible Assets is likely to grow to about 847.1 M, while Deferred Long Term Asset Charges is likely to drop about 2.2 M.
As of the 25th of April 2024, Net Income Applicable To Common Shares is likely to grow to about 224.5 M, while Common Stock Shares Outstanding is likely to drop about 29.9 M.

Repligen Workforce Comparison

Repligen is rated third in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 100,507. Repligen claims roughly 1,783 in number of employees contributing just under 2% to equities under Health Care industry.

Repligen Profit Margins

The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.50.445
Moderately Up
Pretty Stable

Repligen Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Repligen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Repligen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Repligen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-03-01
0.963
26
27
 94,399 
 46,816 
2023-12-01
1.0
2
2
 37,142 
 4,788 
2023-09-01
4.0
4
1
 30,811 
 850.00 
2023-06-01
4.25
17
4
 17,066 
 2,088 
2023-03-01
1.1176
19
17
 114,598 
 35,994 
2022-12-01
4.0
4
1
 50,932 
 25,000 
2022-09-01
1.2727
14
11
 33,358 
 53,098 
2022-06-01
1.7778
16
9
 25,152 
 16,809 
2022-03-01
1.087
25
23
 118,226 
 39,063 
2021-12-01
0.2333
7
30
 21,208 
 42,411 
2021-09-01
0.2368
9
38
 66,735 
 66,371 
2021-06-01
0.8824
15
17
 28,768 
 49,941 
2021-03-01
0.2
11
55
 33,478 
 97,842 
2020-12-01
0.3846
5
13
 26,847 
 52,567 
2020-09-01
0.4444
4
9
 54,569 
 103,797 
2020-06-01
0.4912
28
57
 132,763 
 240,186 
2020-03-01
0.3864
17
44
 97,551 
 177,901 
2019-12-01
0.6667
2
3
 3,957 
 4,252 
2019-09-01
0.0833
1
12
 20,000 
 35,989 
2019-06-01
1.7778
16
9
 79,405 
 60,295 
2019-03-01
1.0909
12
11
 109,142 
 48,437 
2018-12-01
0.5714
4
7
 31,753 
 65,580 
2018-09-01
0.3333
5
15
 16,301 
 237,568 
2018-06-01
0.75
15
20
 78,022 
 518,257 
2018-03-01
1.2
12
10
 620,835 
 49,657 
2017-12-01
0.6
3
5
 12,729 
 925,458 
2017-06-01
12.0
12
1
 23,373 
 2,275 
2017-03-01
1.0667
16
15
 303,765 
 74,292 
2016-09-01
0.5
1
2
 20,000 
 3,024 
2016-06-01
2.125
17
8
 68,062 
 51,493 
2016-03-01
2.0
10
5
 178,940 
 6,484 
2015-12-01
3.0
3
1
 7,000 
 5,000 
2015-09-01
1.0
1
1
 24,000 
 325.00 
2015-06-01
1.4
14
10
 26,388 
 232,625 
2015-03-01
1.25
10
8
 119,519 
 128,483 
2014-12-01
0.625
5
8
 62,000 
 126,158 
2014-09-01
1.0
3
3
 20,000 
 45,000 
2014-06-01
0.9459
35
37
 514,181 
 589,312 
2014-03-01
10.0
10
1
 142,524 
 40,000 
2013-09-01
0.3333
1
3
 50,000 
 109,858 
2013-06-01
0.5455
18
33
 310,016 
 504,087 
2013-03-01
1.2857
9
7
 385,000 
 179,973 
2012-09-01
0.3333
8
24
 102,000 
 400,000 
2012-03-01
0.3846
5
13
 160,000 
 341,551 
2011-09-01
2.0
2
1
 31,000 
 25,000 
2011-03-01
0.25
1
4
 5,000 
 85,000 
2009-09-01
1.25
5
4
 104,000 
 451,800 
2008-09-01
3.0
6
2
 109,000 
 10,000 
2008-03-01
0.1304
3
23
 115,000 
 76,368 
2007-12-01
0.5556
10
18
 155,400 
 92,600 
2007-09-01
3.5
7
2
 860,000 
 139,465 
2007-06-01
1.2857
9
7
 127,000 
 89,444 
2007-03-01
0.3571
5
14
 160,000 
 78,000 
2006-09-01
2.2
11
5
 108,000 
 65,000 
2006-03-01
0.8333
15
18
 596,500 
 236,400 
2005-12-01
2.0
6
3
 17,000 
 36,576 
2005-09-01
0.4615
6
13
 85,000 
 60,425 
2005-06-01
6.0
6
1
 175,000 
 15,000 
2005-03-01
2.5
5
2
 45,000 
 20,000 
2004-09-01
6.0
6
1
 85,000 
 24,000 
2004-06-01
1.75
7
4
 220,000 
 25,000 
2004-03-01
0.5
1
2
 5,000 
 5,000 
2003-12-01
1.25
20
16
 140,000 
 128,000 

Repligen Notable Stakeholders

A Repligen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Repligen often face trade-offs trying to please all of them. Repligen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Repligen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Anthony HuntPresident CEO, DirectorProfile
Alexander RichIndependent Chairman Emeritus of the BoardProfile
Olivier LoeillotPresident OfficerProfile
Ralf KuriyelSenior Vice President - Research & DevelopmentProfile
Tony HuntCOO, TreasurerProfile
James RuscheSr. VP of RandDProfile
Thomas RyanIndependent DirectorProfile
Glenn MuirDirectorProfile
Alfred GoldbergIndependent DirectorProfile
Glenn CooperIndependent DirectorProfile
John CoxDirectorProfile
Nicolas BarthelemyDirectorProfile
Michael GriffithIndependent DirectorProfile
Howard BenjaminVP of Bus. Devel.Profile
Mark SalernoVP AnalyticsProfile
Christine GebskiSenior ChromatographyProfile
Kimberly CornwellGeneral CounselProfile
James BylundChief OfficerProfile
Rachel GoodrichVP MarketingProfile
Neil WhitfieldVice SalesProfile
Keith RobinsonChief OfficerProfile
Sondra NewmanGlobal RelationsProfile
Craig HarrisonVP AnalyticsProfile
Dianne HeilerSenior SustainabilityProfile
Kola OtitojuSenior DevelopmentProfile
Stephen TingleyVP SalesProfile
Jaime HumaraSenior MarketingProfile
Jon SnodgresChief OfficerProfile
Leslie GalvinGlobal ResourcesProfile
Karen DawesIndependent Chairperson of the BoardProfile
Jason GarlandChief OfficerProfile

About Repligen Management Performance

The success or failure of an entity such as Repligen often depends on how effective the management is. Repligen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Repligen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Repligen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.03  0.03 
Return On Capital Employed 0.02  0.02 
Return On Assets 0.01  0.02 
Return On Equity 0.02  0.02 
The data published in Repligen's official financial statements usually reflect Repligen's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Repligen. For example, before you start analyzing numbers published by Repligen accountants, it's critical to develop an understanding of what Repligen's liquidity, profitability, and earnings quality are in the context of the Life Sciences Tools & Services space in which it operates.
Please note, the presentation of Repligen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Repligen's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Repligen's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Repligen. Please utilize our Beneish M Score to check the likelihood of Repligen's management manipulating its earnings.

Repligen Workforce Analysis

Traditionally, organizations such as Repligen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Repligen within its industry.

Repligen Manpower Efficiency

Return on Repligen Manpower

Revenue Per Employee358.3K
Revenue Per Executive20.6M
Net Income Per Employee23.3K
Net Income Per Executive1.3M
Working Capital Per Employee534.4K
Working Capital Per Executive30.7M
When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.
Note that the Repligen information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Repligen Stock analysis

When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.55)
Earnings Share
0.74
Revenue Per Share
11.464
Quarterly Revenue Growth
(0.17)
Return On Assets
0.0131
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.